Data gathered: June 30
Alternative Data for Bolt Biotherapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 7 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 832 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Bolt Biotherapeutics
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.
| Price | $5.77 |
| Target Price | Sign up |
| Volume | 20,870 |
| Market Cap | $11M |
| Year Range | $5.59 - $13.59 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Large Decline in Short InterestJune 12 - ETF Daily News |
|
Citadel Advisors LLC Acquires Shares of 78,961 Bolt Biotherapeutics, Inc. (NASDAQ:BOLT)June 12 - ETF Daily News |
 |
Bolt Biotherapeutics (NASDAQ:BOLT) Research Coverage Started at Lake Street CapitalMay 22 - ETF Daily News |
|
Leerink Partnrs Has Positive Estimate for BOLT Q2 EarningsMay 15 - ETF Daily News |
|
Bolt Biotherapeutics (NASDAQ:BOLT) Price Target Cut to $1.00 by Analysts at Stifel NicolausMay 14 - ETF Daily News |
|
Bolt Biotherapeutics (BOLT) Expected to Announce Earnings on TuesdayMay 11 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 1.2M | 0 | 1.2M | -11M | -12M | -0.290 |
| Q4 '24 | 0 | 0 | 0 | -16M | -16M | -0.420 |
| Q3 '24 | 1.1M | 0 | 1.1M | -15M | -16M | -0.400 |
| Q2 '24 | 1.3M | 15M | -14M | -21M | -19M | -0.460 |
| Q1 '24 | 5.3M | 460,000 | 4.8M | -11M | -17M | -0.280 |
Insider Transactions View All
| Quinn William P. filed to buy 41,272 shares at $0.5. May 5 '25 |
| Nemec Sarah filed to buy 16,633 shares at $0.5. May 5 '25 |
| Quinn William P. filed to buy 36,272 shares at $1. December 13 '23 |
| Quinn William P. filed to buy 28,772 shares at $0.8. December 13 '23 |
| Schatzman Randall C filed to buy 12,859 shares at $0.8. February 6 '24 |
Similar companies
Read more about Bolt Biotherapeutics (BOLT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Bolt Biotherapeutics?
The Market Cap of Bolt Biotherapeutics is $11M.
What is the current stock price of Bolt Biotherapeutics?
Currently, the price of one share of Bolt Biotherapeutics stock is $5.77.
How can I analyze the BOLT stock price chart for investment decisions?
The BOLT stock price chart above provides a comprehensive visual representation of Bolt Biotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bolt Biotherapeutics shares. Our platform offers an up-to-date BOLT stock price chart, along with technical data analysis and alternative data insights.
Does BOLT offer dividends to its shareholders?
As of our latest update, Bolt Biotherapeutics (BOLT) does not offer dividends to its shareholders. Investors interested in Bolt Biotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bolt Biotherapeutics?
Some of the similar stocks of Bolt Biotherapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.